NBTX
LIVE

Serial Number

90048251

Owner

NANOBIOTIX

Attorney

James R Menker

Filing Date

Jul 11, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NBTX Trademark

Serial Number: 90048251 • Registration: 6624908

NBTX is a trademark filed by NANOBIOTIX on July 11, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

NANOBIOTIX (26 trademarks)

60 rue de Wattignies

Entity Type: 99

Trademark Details

Filing Date

July 11, 2020

Registration Date

January 25, 2022

Published for Opposition

November 9, 2021

Goods & Services

Pharmaceutical products, namely, preparations for medical use particularly for the diagnosis and treatment of tumors; pharmaceutical products, namely, preparations for medical use particularly for the diagnosis and treatment of tumors using radiotherapy; pharmaceutical products, namely, preparations for medical use particularly for the diagnosis and treatment of tumors using radiotherapy and immunotherapy; X-ray enhancing agents for medical use for the diagnosis and treatment of tumors using radiotherapy, namely, radioenhancers; X-ray contrast agents for medical use for the diagnosis and treatment of tumors using radiotherapy, namely, radioenhancers; health goods, namely, pharmaceutical preparations for the treatment of tumors using radiotherapy and for the treatment of tumors using radiotherapy and immunotherapy; radiological contrast substances for medical use; nanoparticles for medical use; biological preparations with metallic nanoparticles and/or metal oxides for medical use; chemical preparations with metallic nanoparticles and/or metal oxides for medical or pharmaceutical use; medicinal products, namely, radioenhancers based on metallic nanoparticles and/or metal oxides for medical use for human medicine; chemical pharmaceutical products with metallic nanoparticles and/or metal oxides for the diagnosis of cancer

Injectable medical device containing inert metal for the diagnosis and treatment of tumors

Filing History

REGISTERED-PRINCIPAL REGISTER
Jan 25, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 4, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 4, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 4, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 4, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 27, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 9, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 9, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jul 9, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2021 CRFA
ASSIGNED TO LIE
Jun 22, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 8, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 8, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 8, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2020 NWOS
NEW APPLICATION ENTERED
Jul 15, 2020 NWAP